BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3887672)

  • 1. Evaluation of the Du Pont Theophylline Assay adapted to a centrifugal analyzer.
    Boeckx RL; Munson ST
    Ther Drug Monit; 1985; 7(1):95-100. PubMed ID: 3887672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Particle-enhanced turbidimetric inhibition immunoassay for theophylline evaluated with the Du Pont aca.
    Opheim KE; Glick MR; Ou CN; Ryder KW; Hood LC; Ainardi V; Collymore LA; DeArmas W; Frawley VL; Hutchinson J
    Clin Chem; 1984 Nov; 30(11):1870-4. PubMed ID: 6386231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of particle-enhanced turbidimetric inhibition immunoassay and fluorescence polarization immunoassay using monoclonal antibodies for theophylline.
    Lawrence JL; Elser RC
    Ther Drug Monit; 1986; 8(2):228-31. PubMed ID: 3726940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of EMIT reagent system using a COBAS-BIO centrifugal analyzer.
    Ou CN; Frawley VL; Buffone GJ
    J Anal Toxicol; 1981; 5(5):249-52. PubMed ID: 7033663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homogeneous enzyme immunoassay for theophylline with a centrifugal analyzer.
    Lacher DA; Sinn JA; Savory J; Wills MR
    Ann Clin Lab Sci; 1980; 10(4):305-10. PubMed ID: 7004330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of caffeine plasma levels by an automated enzyme immunoassay (EMIT) in comparison with a high-performance liquid chromatographic method.
    Zysset T; Wahlländer A; Preisig R
    Ther Drug Monit; 1984; 6(3):348-54. PubMed ID: 6390797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Particle-enhanced turbidimetric inhibition immunoassay of theophylline adapted to the Cobas-Bio centrifugal analyzer.
    Liedtke RJ
    Clin Chem; 1984 Jul; 30(7):1274-5. PubMed ID: 6733924
    [No Abstract]   [Full Text] [Related]  

  • 8. A Comparison of the Immunochemical Methods, PETINIA and EMIT, With That of HPLC-UV for the Routine Monitoring of Mycophenolic Acid in Heart Transplant Patients.
    Kunicki PK; Pawiński T; Boczek A; Waś J; Bodnar-Broniarczyk M
    Ther Drug Monit; 2015 Jun; 37(3):311-8. PubMed ID: 25380305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analytical validation of a homogeneous immunoassay for determination of mycophenolic acid in human plasma.
    Vergara Chozas JM; Sáez-Benito Godino A; Zopeque García N; García Pinteño S; Joumady I; Carrasco García C; Vara Gil F
    Transplant Proc; 2012 Nov; 44(9):2669-72. PubMed ID: 23146489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of mycophenolic acid concentrations determined by a new PETINIA assay on the dimension EXL analyzer and a HPLC-UV method.
    Dasgupta A; Tso G; Chow L
    Clin Biochem; 2013 May; 46(7-8):685-7. PubMed ID: 23219740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxyzine and metabolites as a source of interference in carbamazepine particle-enhanced turbidimetric inhibition immunoassay (PETINIA).
    Parant F; Moulsma M; Gagnieu MC; Lardet G
    Ther Drug Monit; 2005 Aug; 27(4):457-62. PubMed ID: 16044102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methods of theophylline assay and therapeutic monitoring of this drug.
    Mounié J; Richard L; Ribon B; Hersant J; Sarmini H; Houin G
    Ann Biol Clin (Paris); 1990; 48(5):287-93. PubMed ID: 2195925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assay of theophylline: comparison of EMIT on the ABA-100 to HPLC, GLC and UV procedures, with detailed evaluation of interferences.
    Weidner N; McDonald JM; Tieber VL; Smith CH; Kessler G; Ladenson JH; Dietzler DN
    Clin Chim Acta; 1979 Sep; 97(1):9-17. PubMed ID: 387295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between theophylline analysis by nephelometric inhibition immunoassay and high performance liquid chromatography.
    Mordelet-Dambrine M; Baglin JY; Roux A; Dusser D; Flouvat B; Huchon G
    Ther Drug Monit; 1986; 8(1):106-10. PubMed ID: 3961886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Particle-enhanced turbidimetric inhibition immunoassay for theophylline with a centrifugal analyzer.
    Gotelli G; Mitchell M
    Clin Chem; 1985 Jun; 31(6):1085-6. PubMed ID: 3995745
    [No Abstract]   [Full Text] [Related]  

  • 16. Theophylline homogeneous enzyme immunoassay (Syva EMIT) adapted to the Cobas-Bio Centrifugal Analyzer.
    Randall GL; Williamson LJ; Batjer JD
    Ther Drug Monit; 1981; 3(3):311-2. PubMed ID: 7034305
    [No Abstract]   [Full Text] [Related]  

  • 17. Quantitative determination of theophylline by an automated chemiluminescent immunoassay in serum and plasma: comparison to other methods of analysis.
    Malliaros DP; Wong SS; Wu AH; Campbell J; Leonard H; Houser S; Berg M; Gornet T; Brown C; Feng YJ
    Ther Drug Monit; 1997 Apr; 19(2):224-9. PubMed ID: 9108655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of a high performance liquid chromatographic and an enzyme immunoassay technique for quantitation of theophylline in serum.
    Boeckx RL; Frith EM; Simons FE
    Ther Drug Monit; 1979; 1(1):65-73. PubMed ID: 399811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the EMIT reagent system for measurement of caffeine with the EMIT Lab 5000 System and a centrifugal analyzer.
    Ou CN; Frawley VL; Ellis JM
    Clin Chem; 1984 Jun; 30(6):887-9. PubMed ID: 6373054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rate turbidimetric immunoassay for theophylline using biotin-avidin system.
    Oh C; Kim J; Kearns B; Cheng A; Dobashi T
    Clin Chim Acta; 1993 Sep; 218(1):59-71. PubMed ID: 8299221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.